文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.

作者信息

Calvete Oriol, Martinez Paula, Garcia-Pavia Pablo, Benitez-Buelga Carlos, Paumard-Hernández Beatriz, Fernandez Victoria, Dominguez Fernando, Salas Clara, Romero-Laorden Nuria, Garcia-Donas Jesus, Carrillo Jaime, Perona Rosario, Triviño Juan Carlos, Andrés Raquel, Cano Juana María, Rivera Bárbara, Alonso-Pulpon Luis, Setien Fernando, Esteller Manel, Rodriguez-Perales Sandra, Bougeard Gaelle, Frebourg Tierry, Urioste Miguel, Blasco Maria A, Benítez Javier

机构信息

Human Genetics Group, Spanish National Cancer Research Center (CNIO), Melchor Fernandez Almagro 3, Madrid 28029, Spain.

Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid 28029, Spain.

出版信息

Nat Commun. 2015 Sep 25;6:8383. doi: 10.1038/ncomms9383.


DOI:10.1038/ncomms9383
PMID:26403419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4598567/
Abstract

Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li-Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121,324 studied alleles in ExAC server but it is not described in any other database or found in 1,520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.

摘要

相似文献

[1]
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.

Nat Commun. 2015-9-25

[2]
The wide spectrum of POT1 gene variants correlates with multiple cancer types.

Eur J Hum Genet. 2017-11

[3]
A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.

PLoS Genet. 2022-6

[4]
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.

J Am Heart Assoc. 2019-9-12

[5]
Whole exome sequencing identified a novel variant as a candidate pathogenic allele underlying a Li-Fraumeni-like family.

Front Oncol. 2022-11-1

[6]
TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.

Fam Cancer. 2017-4

[7]
mutation spectrum in tumour types commonly diagnosed among -associated hereditary cancer syndrome families.

J Med Genet. 2020-10

[8]
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.

Cancer. 2013-10-7

[9]
Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

Br J Haematol. 2018-5

[10]
Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.

Mol Carcinog. 2012-4-11

引用本文的文献

[1]
POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers.

Acta Oncol. 2025-8-25

[2]
Germline Variants in a Pan-Cancer Cohort.

JCO Precis Oncol. 2025-7

[3]
Active telomere elongation by a subclass of cancer-associated POT1 mutations.

Genes Dev. 2025-4-1

[4]
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Exp Hematol Oncol. 2025-1-27

[5]
Telomere maintenance and the DNA damage response: a paradoxical alliance.

Front Cell Dev Biol. 2024-10-17

[6]
Genomic landscape and preclinical models of angiosarcoma.

Mol Oncol. 2025-4

[7]
Identification and functional validation of a novel pathogenic germline variant p.G95V in familial melanoma.

JEADV Clin Pract. 2024-9

[8]
Telomeres and telomerase in Sarcoma disease and therapy.

Int J Med Sci. 2024

[9]
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.

Nat Genet. 2024-9

[10]
approaches for drug repurposing in oncology: a scoping review.

Front Pharmacol. 2024-6-11

本文引用的文献

[1]
Shelterin proteins and cancer.

Asian Pac J Cancer Prev. 2015

[2]
Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients.

Breast Cancer Res Treat. 2015-1

[3]
Germline mutations in shelterin complex genes are associated with familial glioma.

J Natl Cancer Inst. 2014-12-7

[4]
PredictProtein--an open resource for online prediction of protein structural and functional features.

Nucleic Acids Res. 2014-5-5

[5]
The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.

Orphanet J Rare Dis. 2014-4-28

[6]
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

Hum Mutat. 2014-6

[7]
POT1 loss-of-function variants predispose to familial melanoma.

Nat Genet. 2014-3-30

[8]
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.

Nat Genet. 2014-3-30

[9]
Primary cardiac angiosarcoma - a review.

Med Sci Monit. 2014-1-23

[10]
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.

Mod Pathol. 2013-6-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索